DHAKA: Bangladesh could receive 1 million doses of AstraZeneca COVID-19 vaccine from the WHO-backed COVAX facility this month, and the Serum Institute of India could resume supplies from August, its health minister said on Tuesday .
He said SII could resume direct supplies of Covishield, a licensed version of the AstraZeneca shot to Bangladesh from next month. Indian producers including SII, the main supplier to COVAX, stopped all vaccine exports in the middle of April to meet local demand as infections shot up. Bangladesh has a deal for 30 million Covishield doses with SII but has only received 7 million, which it has used to fully immunise about 3 per cent of its 170 million people.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.